Clinical Trials Logo

Clinical Trial Summary

Transnasal humidified rapid-insufflation ventilatory exchange(THRIVE), or also termed high flow nasal oxygenation (HFNO) is a method of supplying heated, humidified high concentrations of oxygen via nasal cavity. The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery.


Clinical Trial Description

HFNO can be used during intraoperative period. HFNO reduces the risk of desaturation and prolongs the safe apnea time, compared with conventional oxygenation. In laryngeal microsurgery, HFNO therapy make possible to perform tubeless anesthesia, providing perfect exposure of structure of the vocal cords. HFNO have a risk for low level of positive pressure can make gastric distension, but gastric reflux or aspiration were not occurred during rapid sequence induction for emergency operation. The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04629911
Study type Interventional
Source Ajou University School of Medicine
Contact
Status Completed
Phase N/A
Start date November 23, 2020
Completion date August 24, 2021

See also
  Status Clinical Trial Phase
Completed NCT03134937 - High-Flow Heated and Humidified Oxygen Therapy and Gastric Distension N/A